New Frontiers in Proteomics: Early Cancer Detection
Recent progresses in proteomics have unveiled promising pathways for early cancer detection and treatment.
New Frontiers in Proteomics: Early Cancer Detection Read More »
Autoimmune and autoinflammatory arthritis: HMGB1 as a biomarker and therapeutic target
On May 20th, World AUTOimmune & AUTOinflammatory Arthritis Day, highlights the global impact of autoimmune and autoinflammatory arthritis, affecting an estimated 450 million people worldwide.
Autoimmune and autoinflammatory arthritis: HMGB1 as a biomarker and therapeutic target Read More »
HMGB1 Protein in Pancreatic Cancer Progression
Pancreatic ductal adenocarcinoma (PDAC), characterized by aggressive nature and low survival rates, has been the focus of recent studies highlighting the role of High Mobility Group Box 1 (HMGB1).
HMGB1 Protein in Pancreatic Cancer Progression Read More »
The Role of HMGB1 in the Female Reproductive System: Happy Mother’s Day
High-mobility group box 1 (HMGB1) protein is increasingly recognized for its significant roles within the female reproductive system.
The Role of HMGB1 in the Female Reproductive System: Happy Mother’s Day Read More »
HMGB1 as a common biomarker in autism and nervous system diseases
Autism Awareness Month has highlighted the focus on underlying biological mechanisms that influence autism and nervous system conditions.
HMGB1 as a common biomarker in autism and nervous system diseases Read More »
Kidney Diseases: HMGB1 as a Potential Therapeutic Strategy
Has been underscored HMGB1’s potential as a strategic target for therapeutic intervention in chronic kidney diseases (CKD).
Kidney Diseases: HMGB1 as a Potential Therapeutic Strategy Read More »
Unraveling Autism’s complexities through Epigenetics and Neuroimmunology
Among others, HMGB1 protein has been identified for its significant role in the pathology of autism and neurological conditions.
Unraveling Autism’s complexities through Epigenetics and Neuroimmunology Read More »
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination
A relevant research concerning a wider perspective on protective immunity has just been published: Maura Casalgrandi, researcher in HMGBiotech, is one of the authors involved in the study.
HMGB1: an essential regulator in the interplay between Autophagy and Apoptosis in Cancer Therapy
Recent insights reveal HMGB1’s central function in regulating the interplay between autophagy and apoptosis, processes essential for maintaining cellular homeostasis and determining the fate of cancer cells.
